Roxadustat: A promising treatment for anaemia in chronic kidney disease

ResearchPod

English - August 26, 2022 09:00 - 9 minutes - 6.61 MB
Science Technology science research outreach education stem learning academic technology impact scicomm Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: How Festivals Bring Mutual Understanding and Harmony to Southeast Asia

Next Episode: Cilia proteins as biomarkers of altered flow

More than one in seven people in the US have chronic kidney disease (CKD), making it one of the top causes of death. Anaemia is a common, though under-treated complication.

Dr Robert Provenzano of Wayne State University and his team pooled together the results of three randomised clinical trials to investigate the efficacy and safety of of new treatment, Roxadustat, in managing the blood disease risks of CKD patients.

Read the original article: doi.org/10.2215/CJN.16191020

Read more in Research Features